AHRQ's Comparative Effectiveness Research on Lipid-Modifying Therapies- Describe the long-term clinical benefits and harms of increased doses of statin monotherapy versus the combination of a statin and another cholesterol-lowering agent for patients requiring intensive therapy. Review the effects of higher-dose statin monotherapy versus combination therapy on cholesterol targets, short-term side effects, tolerability, and adherence. Summarize the comparative benefits and harms of higher-dose statin monotherapy versus combination therapies in selected patient subgroups. Apply relevant findings to patient-centered treatment decisions, education, and promotion of adherence
1.0 Free Contact Hours for Nurse Practitioner
s which includes 0.5 hours of pharmacology
